Speaker
Chief Technology Officer, Gefjon Pharma
Fabio Antenucci, Chief Technology Officer at Gefjon Pharma, spoke at 8th Exosome-Based Therapeutics Development Summit (Boston, United States of America, 22–24 Sept 2026) in the session “Engineering Scalable Biologics: Gefjon Pharma's Modular OMV Platform for High-Yield, Cost-Effective Production, Powered by NorthX Biologics' Extensive GMP Manufacturing Expertise”.
22–24 Sept 2026Boston, United States of America
Senior Director - International Business Development, Daicel Life Sciences
Senior Principal, Regenerative Medicine, Dark Horse Consulting Group
Research & Development Director, Neucore Bio
Hemato-Oncologist, Centro Oncologico de Antioquia
Chief Executive Officer, Aegle Therapeutics
R&D Director, NurExone
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Fabio Antenucci, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].